Galecto to Participate in Upcoming Investor Conferences
Galecto Anticipates That Its Cash, Cash Equivalents and Investments Will Be Sufficient to Fund Operating Expenses and Cap Requirements for at Least the Next Twelve Mos >GLTO
Galecto Cash, Cash Equivalents, and Investments as of Sept 30 Were $19.7M >GLTO
Express News | Galecto Reports Third Quarter 2024 Financial Results
Galecto 3Q Loss/Shr $3.39 >GLTO
Galecto 3Q Loss $3.88M >GLTO
Press Release: Galecto Reports Third Quarter 2024 Financial Results
Galecto | 10-Q: Q3 2024 Earnings Report
Galecto Is Maintained at Outperform by Oppenheimer
Galecto Analyst Ratings
Oppenheimer Maintains Galecto(GLTO.US) With Buy Rating, Cuts Target Price to $10
Express News | Galecto Inc : Oppenheimer Raises Target Price to $10 From $9
Galecto Price Target Raised to $10 From $9 at Oppenheimer
Oppenheimer Sticks to Its Buy Rating for Galecto (GLTO)
Galecto Announces the Appointment of Wechsler to Its Board of Directors
Express News | Galecto Strengthens Board of Directors With Appointment of DR. Amy Wechsler
Press Release: Galecto Strengthens Board of Directors With Appointment of Dr. Amy Wechsler
Sector Update: Health Care Stocks Softer Monday Afternoon
12 Health Care Stocks Moving In Monday's Intraday Session
Why Galecto (GLTO) Shares Are Down 27% Today